News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
8,172 Results
Type
Article (703)
Company Profile (2)
Press Release (7467)
Multimedia
Podcasts (4)
Webinars (1)
Section
Business (2757)
Career Advice (16)
Deals (372)
Drug Delivery (5)
Drug Development (1273)
Employer Resources (3)
FDA (245)
Job Trends (159)
News (4577)
Policy (352)
Tag
Academia (31)
Alliances (959)
ALS (1)
Alzheimer's disease (10)
Antibody-drug conjugate (ADC) (4)
Approvals (250)
Artificial intelligence (8)
Autoimmune disease (1)
Bankruptcy (10)
Best Places to Work (94)
BIOSECURE Act (1)
Biosimilars (20)
Biotechnology (1)
Breast cancer (4)
Cancer (47)
Cardiovascular disease (4)
Career advice (15)
Cell therapy (5)
Clinical research (1078)
Collaboration (48)
Compensation (3)
COVID-19 (13)
C-suite (15)
Cystic fibrosis (6)
Data (38)
Diabetes (6)
Diagnostics (38)
Digital health (3)
Drug discovery (1)
Drug pricing (17)
Earnings (752)
Editorial (1)
Employer branding (1)
Employer resources (2)
Events (807)
Executive appointments (16)
FDA (270)
Funding (17)
Generative AI (2)
Gene therapy (6)
GLP-1 (69)
Government (52)
Guidances (4)
Healthcare (137)
Immunology and inflammation (8)
Indications (1)
Infectious disease (16)
Inflammatory bowel disease (3)
Inflation Reduction Act (1)
Influenza (1)
Interviews (4)
IPO (178)
IRA (9)
Job creations (69)
Job search strategy (15)
Labor market (1)
Layoffs (13)
Legal (83)
Lung cancer (17)
Machine learning (1)
Management (1)
Manufacturing (3)
MASH (14)
Medical device (72)
Medtech (72)
Mergers & acquisitions (189)
Metabolic disorders (39)
NASH (6)
Neurodegenerative disease (7)
Neuropsychiatric disorders (2)
Neuroscience (25)
NextGen: Class of 2025 (69)
Non-profit (36)
Now hiring (1)
Obesity (24)
Opinion (7)
Ovarian cancer (1)
Parkinson's disease (2)
Patents (4)
People (939)
Pharmaceutical (1)
Pharmacy benefit managers (3)
Phase I (254)
Phase II (444)
Phase III (407)
Pipeline (40)
Policy (11)
Postmarket research (115)
Preclinical (81)
Rare diseases (10)
Real estate (72)
Recruiting (1)
Regulatory (255)
Reports (1)
Research institute (28)
Resumes & cover letters (1)
RNA editing (1)
Schizophrenia (7)
Series A (5)
Series B (5)
Special edition (1)
Startups (60)
The Weekly (4)
Vaccines (7)
Venture capital (2)
Weight loss (20)
Date
Last 7 days (6)
Last 30 days (16)
Last 365 days (310)
2025 (249)
2024 (414)
2023 (371)
2022 (667)
2021 (669)
2020 (584)
2019 (520)
2018 (377)
2017 (536)
2016 (489)
2015 (451)
2014 (374)
2013 (333)
2012 (325)
2011 (309)
2010 (336)
Location
Africa (19)
Alabama (1)
Arizona (2)
Asia (256)
Australia (66)
California (181)
Canada (3)
China (5)
Colorado (1)
Connecticut (18)
Europe (2222)
Florida (2)
Georgia (5)
Illinois (7)
India (1)
Indiana (7)
Japan (4)
Kansas (1)
Maryland (1)
Massachusetts (33)
Michigan (1)
Missouri (1)
New Hampshire (1)
New Jersey (4)
New York (9)
North Carolina (5)
Northern California (51)
Oklahoma (1)
Oregon (1)
Pennsylvania (4)
South America (20)
Southern California (76)
Texas (2)
United States (293)
Utah (1)
Virginia (1)
Washington D.C. (2)
Washington State (15)
8,172 Results for "boehringer ingelheim fremont".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Numab Therapeutics Achieves Milestone in Collaboration with Boehringer Ingelheim
September 26, 2025
·
2 min read
Press Releases
Boehringer Ingelheim Obtains Novel Preclinical Oncology Program from Accent Therapeutics
October 9, 2025
·
2 min read
Approvals
Boehringer Ingelheim Breaks Decade-Long Approval Drought in Idiopathic Pulmonary Fibrosis
In the Phase III FIBRONEER-IPF study, Jascayd demonstrated significant lung capacity improvements over placebo.
October 8, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Boehringer Ingelheim launches new direct-to-consumer platform to expand patient access to important treatments
September 30, 2025
·
4 min read
Lung cancer
140-Year-Old Boehringer Ingelheim Dives Into Cancer With NSCLC Nod
Phase Ib data show Hernexeos can elicit a confirmed objective response rate of 44% in patients with HER2-mutated NSCLC who had previously been treated with a directed antibody-drug conjugate.
August 11, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Palatin Earns €5.5 Million ($6.5 Million) Milestone Payment in Retinal Disease Collaboration with Boehringer Ingelheim
September 23, 2025
·
3 min read
Press Releases
Boehringer Ingelheim Launches Swine Vaccine With Advanced Protection Against Porcine Circovirus Type 2 in the United States
September 4, 2025
·
4 min read
Press Releases
Boehringer Ingelheim Celebrates Next Generation of Biomedical Researchers at 2025 Veterinary Scholars Symposium
August 12, 2025
·
5 min read
Collaboration
Boehringer Ingelheim Expands Cancer Pipeline With Back-to-Back Antibody Deals
On Thursday, Boehringer Ingelheim announced a partnership with Synaffix to advance antibody-drug conjugates and exercised its fourth license option under a 2013 collaboration with Oxford BioTherapeutics.
January 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Boehringer Ingelheim Harnesses GenAI to Transform Case Intake with LifeSphere® NavaX™
July 8, 2025
·
2 min read
1 of 818
Next
